Location: New York, NY
CIK: 0001974915 · Show all filings
Period: Q4 2023 (Next →)
Filing Date: Feb 13, 2024
Total Value: $944M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 800,000 | $105M | 11.2% | $115.11 | 0.0% | COM | 64125C109 |
| JAZZ | Jazz Pharmaceuticals PLC | 725,000 | $89.17M | 9.4% | $124.79 | 0.0% | SHS USD | G50871105 |
| ASND | Ascendis Pharma A/S | 625,000 | $78.72M | 8.3% | $125.95 | — | SPONSORED ADR | 04351P101 |
| — | Inhibrx Inc | 1,530,000 | $58.14M | 6.2% | $38.00 | — | COM | 45720L107 |
| SLNO | Soleno Therapeutics Inc | 1,300,000 | $52.33M | 5.5% | $28.45 | 0.0% | COM | 834203309 |
| MRK | Merck & Co Inc | 400,000 | $43.61M | 4.6% | $96.81 | 0.0% | COM | 58933Y105 |
| GMED | Globus Medical Inc | 800,000 | $42.63M | 4.5% | $48.74 | 0.0% | CL A | 379577208 |
| PCRX | Pacira BioSciences Inc | 1,200,000 | $40.49M | 4.3% | $29.26 | 0.0% | COM | 695127100 |
| — | Cymabay Therapeutics Inc | 1,625,000 | $38.38M | 4.1% | $23.62 | — | COM | 23257D103 |
| PCVX | Vaxcyte Inc | 525,000 | $32.97M | 3.5% | $51.94 | 0.0% | COM | 92243G108 |
| INSM | Insmed Inc | 900,000 | $27.89M | 3.0% | $25.93 | 0.0% | COM PAR $.01 | 457669307 |
| QURE | uniQure NV | 3,925,000 | $26.57M | 2.8% | $6.61 | 0.0% | SHS | N90064101 |
| ALXO | ALX Oncology Holdings Inc | 1,655,000 | $24.64M | 2.6% | $9.49 | 0.0% | COM | 00166B105 |
| IMTX | Immatics NV | 2,100,000 | $22.11M | 2.3% | $9.21 | 0.0% | SHS | N44445109 |
| VRDN | Viridian Therapeutics Inc | 1,000,000 | $21.78M | 2.3% | $15.79 | 0.0% | COM | 92790C104 |
| RVMD | REVOLUTION Medicines Inc | 725,000 | $20.79M | 2.2% | $24.03 | 0.0% | COM | 76155X100 |
| BIIB | Biogen Inc | 75,000 | $19.41M | 2.1% | $245.62 | 0.0% | COM | 09062X103 |
| EW | Edwards Lifesciences Corp | 225,000 | $17.16M | 1.8% | $69.58 | 0.0% | COM | 28176E108 |
| AZN | AstraZeneca PLC | 250,000 | $16.84M | 1.8% | $67.35 | — | SPONSORED ADR | 046353108 |
| CRNX | Crinetics Pharmaceuticals Inc | 450,000 | $16.01M | 1.7% | $30.67 | 0.0% | COM | 22663K107 |
| — | Lyra Therapeutics Inc | 3,000,000 | $15.72M | 1.7% | $5.24 | — | COM | 55234L105 |
| SNY | Sanofi SA | 300,000 | $14.92M | 1.6% | $49.73 | — | SPONSORED ADR | 80105N105 |
| NUVL | Nuvalent Inc | 200,000 | $14.72M | 1.6% | $61.88 | 0.0% | COM | 670703107 |
| — | Applied Therapeutics Inc | 4,155,000 | $13.92M | 1.5% | $3.35 | — | COM | 03828A101 |
| LQDA | Liquidia Corp | 1,025,000 | $12.33M | 1.3% | $7.20 | 0.0% | COM NEW | 53635D202 |
| — | Aerovate Therapeutics Inc | 400,000 | $9.052M | 1.0% | $22.63 | — | COM | 008064107 |
| REGN | Regeneron Pharmaceuticals Inc | 10,000 | $8.783M | 0.9% | $818.96 | 0.0% | COM | 75886F107 |
| ARQT | Arcutis Biotherapeutics Inc | 2,700,000 | $8.721M | 0.9% | $2.72 | 0.0% | COM | 03969K108 |
| XENE | Xenon Pharmaceuticals Inc | 175,000 | $8.06M | 0.9% | $35.33 | 0.0% | COM | 98420N105 |
| FULC | Fulcrum Therapeutics Inc | 1,025,000 | $6.919M | 0.7% | $4.44 | 0.0% | COM | 359616109 |
| ALNY | Alnylam Pharmaceuticals Inc | 35,000 | $6.699M | 0.7% | $170.34 | 0.0% | COM | 02043Q107 |
| GLPG | Galapagos NV | 130,000 | $5.285M | 0.6% | $40.65 | — | SPON ADR | 36315X101 |
| FATE | Fate Therapeutics Inc | 1,290,000 | $4.825M | 0.5% | $2.36 | 0.0% | COM | 31189P102 |
| CYTK | Cytokinetics Inc | 50,000 | $4.175M | 0.4% | $36.21 | 0.0% | COM NEW | 23282W605 |
| ACLX | Arcellx Inc | 60,000 | $3.33M | 0.4% | $45.11 | 0.0% | COMMON STOCK | 03940C100 |
| — | Bluebird Bio Inc | 2,150,000 | $2.967M | 0.3% | $1.38 | — | COM | 09609G100 |
| TEVA | Teva Pharmaceutical Industries | 200,000 | $2.088M | 0.2% | $10.44 | — | SPONSORED ADS | 881624209 |
| DNTH | Dianthus Therapeutics Inc | 135,000 | $1.404M | 0.1% | $11.05 | 0.0% | COM | 252828108 |
| — | Chimerix Inc | 1,400,000 | $1.347M | 0.1% | $0.96 | — | COM | 16934W106 |
| PYXS | Pyxis Oncology Inc | 440,000 | $792K | 0.1% | $1.71 | 0.0% | COMMON STOCK | 747324101 |
| — | Reneo Pharmaceuticals Inc | 400,000 | $640K | 0.1% | $1.60 | — | COM | 75974E103 |
| — | Ikena Oncology Inc | 322,671 | $636K | 0.1% | $1.97 | — | COM | 45175G108 |
| RLMD | Relmada Therapeutics Inc | 115,000 | $476K | 0.1% | $2.96 | 0.0% | COM | 75955J402 |
| — | Affimed NV | 546,067 | $341K | 0.0% | $0.63 | — | COM | N01045108 |
| OVID | Ovid therapeutics Inc | 85,429 | $275K | 0.0% | $3.42 | 0.0% | COM | 690469101 |
| SLDB | Solid Biosciences Inc | 34,085 | $209K | 0.0% | $3.20 | 0.0% | COM NEW | 83422E204 |
| PRME | Prime Medicine Inc | 20,306 | $180K | 0.0% | $7.70 | 0.0% | COM | 74168J101 |
| — | Achilles Therapeutics PLC | 108,083 | $96,086 | 0.0% | $0.89 | — | SPONSORED ADS | 00449L102 |